SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (10141)5/4/2009 12:46:08 PM
From: tom pope1 Recommendation  Respond to of 10345
 
I figure it must be something along those lines. Maybe somebody has figured out a way to extricate the pieces from their entanglements.

I always lose money on takeover plays, be warned.



To: Arthur Radley who wrote (10141)5/4/2009 10:26:54 PM
From: Biotech Jim1 Recommendation  Read Replies (2) | Respond to of 10345
 
Though I have no inside information, I bet that Lundbeck is exploring the munch of ELN. The AD and neurodegeneration pipeline is of interest, especially some of the earlier stuff in the clinic, and we all know what Lundbeck paid for the option on the Flurizan program.

BJ


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News